CLINICAL_TRIALS ClinicalTrials.gov record update

Comparison of Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma) With Pentabio® Vaccine Primed With Recombinant Hepatitis B at Birth Dose Using New Hepatitis B Bulk (Bio Farma), in Indonesian Infants

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05482282
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:43.584576+00:00
Published At: 2025-06-05T00:00:00+00:00
Record Updated At: 2025-06-05
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Diphtheria Vaccine Adverse Reaction", "Tetanus Vaccine Adverse Reaction", "Pertussis Vaccine Adverse Reaction", "Haemophilus Influenzae Type B Vaccine Adverse Reaction", "Hepatitis B Vaccine Adverse Reaction"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-06-05"
protocolSection.identificationModule.nctId: "NCT05482282"
protocolSection.identificationModule.officialTitle: "Comparison of Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma) With Pentabio\u00ae Vaccine Primed With Recombinant Hepatitis B at Birth Dose Using New Hepatitis B Bulk (Bio Farma), in Indonesian Infants"
protocolSection.statusModule.overallStatus: "WITHDRAWN"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.